NCT04986592

Brief Summary

In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. The aim of our study was to evaluate the independent risk factors of vocal cord palsy, including those related to pre-dissection nerve monitoring values. Methods: Prospective observational study in 95 consecutive adult patients undergoing elective total thyroidectomy in Spain. A single experienced phonologist performed a videostroboscopy (VS) exam preoperatively and one week after surgery to assess vocal cord mobility. Each surgical procedure was performed with intermittent intraoperative neuromonitoring. Latency and amplitude values were obtained for the vagal and recurrent laryngeal nerves before surgical dissection and compared with the postoperative VS exam.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 3, 2021

Completed
Last Updated

August 5, 2021

Status Verified

August 1, 2021

Enrollment Period

1.1 years

First QC Date

June 16, 2021

Last Update Submit

August 4, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Response amplitude in recurrent laryngeal nerve in uV

    Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (\< 100 uV), and a high-pitched warning sound.

    Adult patients undergoing total thyroidectomy during a 12-month period

  • Response amplitude in vagal nerve in uV

    Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (\< 100 uV), and a high-pitched warning sound.

    Adult patients undergoing total thyroidectomy during a 12-month period

  • Vocal cord palsy

    Vocal cords were assessed using videostroboscopy(Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the neuromonitoring results

    The VS exam was performed one week after surgery, through study completion, an average of 1 yearThe diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent.

You may qualify if:

  • To be at least 18 years old, to accept participation in the study, and to be scheduled for a total bilateral thyroidectomy.

You may not qualify if:

  • Urgent thyroidectomy, inability to perform videostroboscopy, minor patients, patient refuse to be part of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vocal Cord Paralysis

Condition Hierarchy (Ancestors)

Laryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve DiseasesCranial Nerve DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Enric Caubet

    Hospital Vall d'Hebron , Barcelona. Spain

    STUDY DIRECTOR
  • Marcos De Miguel

    Hospital Vall d'Hebron , Barcelona. Spain

    STUDY CHAIR
  • Oscar González

    Hospital Vall d'Hebron , Barcelona. Spain

    STUDY DIRECTOR
  • Mercedes Velasco, Ph

    Hospital Universitari Vall d'Hebron Research Institute

    STUDY CHAIR
  • Miriam De Nadal

    Hospital Vall d'Hebron , Barcelona. Spain

    STUDY CHAIR
  • Eva Pelaez

    Hospital Vall d'Hebron , Barcelona. Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2021

First Posted

August 3, 2021

Study Start

April 1, 2014

Primary Completion

May 1, 2015

Study Completion

December 1, 2015

Last Updated

August 5, 2021

Record last verified: 2021-08